AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bitaquine 40mg Injection

Prescription Icon
Prescription Required

Marketer

Bombay Tablet Mfg Co Pvt Ltd

Salt Composition

Chloroquine (40mg)

Overview Bitaquine 40mg Injection

Malaria is combated with the antiparasitic Bitaquine 40mg Injection, used both prophylactically and therapeutically. Its mechanism involves eliminating the malaria parasite, thereby halting infection spread. Administration is strictly by injection from a healthcare provider; self-injection is strongly discouraged. Mosquito avoidance is crucial; employ insect repellent on exposed skin, spray indoor areas, and wear light-colored, protective clothing after dusk. Potential side effects include weakness, vomiting, rash, itching, abdominal pain, diarrhea, anorexia, nausea, and injection site reactions (pain, swelling, redness). Prolonged side effects necessitate medical consultation. Diabetics should inform their physician, as Bitaquine may induce hypoglycemia, requiring regular blood glucose monitoring. Blurred vision may occur, warranting routine eye exams during treatment. Long-term use may necessitate regular blood cell count monitoring. Report any unexplained bruising, bleeding, sore throat, fever, or fatigue to your doctor immediately.

Primary Ingredients of Bitaquine 40mg Injection

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Bitaquine 40mg Injection

Managing Malaria Infections

Major Benefits of Bitaquine 40mg Injection:

This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.

Common Side effects of Bitaquine 40mg Injection:

  • Weakness
  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Bitaquine 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Bitaquine 40mg Injection works:

Malaria is effectively combated by the antiparasitic Bitaquine 40mg Injection. Its mechanism involves elevating blood haem levels, a compound lethal to the malaria parasite, thus eliminating the parasite and halting disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Bitaquine 40mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Bitaquine 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the 40mg Bitaquine injection pose no known safety risk. Research in humans indicates minimal drug transfer to breast milk, with no identified harm to the infant.

DrivingDrivingUNSAFE

Administering Bitaquine 40mg Injection may induce adverse reactions impacting driving capabilities. Blurred vision or impaired visual focus, occasionally resulting from Bitaquine 40mg Injection, can also compromise safe driving.

KidneyKidneyCAUTION

Administering Bitaquine 40mg Injection to individuals with renal impairment requires careful consideration. Dosage modification for Bitaquine 40mg Injection may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Bitaquine 40mg Injection cautiously, potentially requiring dosage modification. Physician consultation is recommended. Liver function should be regularly assessed during treatment.

What if you forget to take Bitaquine 40mg Injection :

NA

Facts to Know About Bitaquine 40mg Injection

LabelValue
Pharmaceutical Category 4-Aminoquinoline-based compound
Potential for Dependence None.
Treatment Category Eye medication
Mechanism of Action Aminoquinoline antimalarials

FAQs on Bitaquine 40mg Injection

Malaria treatment and prophylaxis are achieved with the antimalarial injection, Bitaquine 40mg.
Malaria symptoms can emerge within a week of an infected mosquito bite. The incubation period typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, manifesting as chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Bitaquine 40mg Injection, as directed by your physician, necessitates regular eye examinations. This is a precaution due to the chloroquine content, which can lead to blurred vision, reading difficulties (characterized by apparent word loss), and, less commonly, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to administering Bitaquine 40mg Injection, as it could potentially exacerbate the condition.
Abdominal discomfort, queasiness, emesis, and cephalalgia are among the frequently reported adverse reactions associated with this medication. Ingesting the medication with food may often mitigate these effects.
Insufficient clinical evidence supports chloroquine's efficacy against COVID-19. Consequently, using Bitaquine 40mg Injection for this purpose without physician consultation is ill-advised.
Allow at least four hours between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as antimalarial drugs. Hydroxychloroquine, though, exhibits a more favorable side effect profile compared to chloroquine. Consequently, hydroxychloroquine enjoys wider current use. Furthermore, hydroxychloroquine holds approvals for treating rheumatoid arthritis and lupus, unlike chloroquine.
Mosquito-borne malaria is avoidable through measures such as wearing protective clothing, employing mosquito nets, and using insect repellent. Consult your physician regarding the necessity of prophylactic antimalarial medication. If prescribed, adhere strictly to the recommended dosage and complete the entire course of treatment.
Malarone 40mg injection treats and prevents malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. The incubation period typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, presenting as chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Bitaquine 40mg Injection, as prescribed by your physician, necessitates routine eye examinations. This is due to the chloroquine component, which may induce blurred vision, reading difficulties (manifested as disappearing text), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to administering Bitaquine 40mg Injection, as it could potentially exacerbate this condition.
This medication may cause common side effects such as abdominal discomfort, queasiness, emesis, and cephalalgia. Ingesting the medication with food may often mitigate these effects.
Insufficient clinical evidence supports chloroquine's efficacy against COVID-19. Consequently, using Bitaquine 40mg Injection for this purpose without physician consultation is strongly discouraged.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as antimalarial drugs. Hydroxychloroquine, however, enjoys wider current usage due to chloroquine's significantly higher incidence of adverse reactions. Furthermore, hydroxychloroquine's therapeutic applications extend to rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by covering exposed skin, using mosquito netting, and applying insect repellent to deter mosquito bites. Consult your physician regarding the necessity of prophylactic antimalarial medication. If prescribed, adhere strictly to the recommended dosage and complete the entire course of treatment.
Bitaquine 40mg Injection
11
MRP 14
21% off